Sulopenem etzadroxil/probenecid

sulopenem etzadroxil/probenecid · Iterum Therapeutics, International Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sulopenem etzadroxil/probenecid, covering 2020-12-17 to 2024-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Use of Sulopenem Etzadroxil/Probenecid for Complicated Urinary Tract Infection